spironolactone has been researched along with chlormadinone acetate in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (50.00) | 18.7374 |
1990's | 2 (25.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Potts, GO; Schane, HP | 1 |
Schindler, AE | 1 |
Cantabrana, B; Garcia Valencia, V; Gutierrez, M; Hidalgo, A; Sanchez, M | 1 |
Cusan, L; Labrie, C; Labrie, F; Lapointe, S; Plante, M | 1 |
Begin, DJ; Labrie, F; Luthy, IA | 1 |
Zaun, H | 1 |
de Sá, MF; dos Reis, RM; Fernandes, JB; Ferriani, RA; Martins, WP; Soares, GM; Vieira, CS | 1 |
1 review(s) available for spironolactone and chlormadinone acetate
Article | Year |
---|---|
[Anti-androgen therapy in the female].
Topics: Androgen Antagonists; Androgens; Chlormadinone Acetate; Cyproterone; Cyproterone Acetate; Female; Humans; Spironolactone | 1990 |
1 trial(s) available for spironolactone and chlormadinone acetate
Article | Year |
---|---|
The effects of 2 mg chlormadinone acetate/30 mcg ethinylestradiol, alone or combined with spironolactone, on cardiovascular risk markers in women with polycystic ovary syndrome.
Topics: Adult; Blood Glucose; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Carotid Arteries; Carotid Intima-Media Thickness; Chlormadinone Acetate; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Insulin; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Risk Factors; Sex Hormone-Binding Globulin; Spironolactone; Testosterone; Triglycerides; Vasodilation | 2012 |
6 other study(ies) available for spironolactone and chlormadinone acetate
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Oral progestational activity of spironolactone.
Topics: Animals; Castration; Chlormadinone Acetate; Endometrium; Estradiol; Female; Macaca mulatta; Menstruation; Progestins; Rabbits; Spironolactone | 1978 |
Effects of steroidal and non-steroidal antiandrogens on the left atrium of the rat in vitro.
Topics: Androgen Antagonists; Animals; Calcium; Chlormadinone Acetate; Cimetidine; Cyproterone; Electric Stimulation; Female; Flutamide; Heart; Heart Atria; In Vitro Techniques; Male; Medroxyprogesterone; Myocardial Contraction; Rats; Rats, Inbred Strains; Spironolactone; Steroids; Stimulation, Chemical | 1991 |
Analysis of the androgenic activity of synthetic "progestins" currently used for the treatment of prostate cancer.
Topics: Adrenal Glands; Animals; Chlormadinone Acetate; Cyproterone; Cyproterone Acetate; Dihydrotestosterone; Flutamide; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Organ Size; Ornithine Decarboxylase; Progesterone Congeners; Prostate; Prostatic Neoplasms; Rats; Rats, Inbred Strains; Spironolactone | 1987 |
Androgenic activity of synthetic progestins and spironolactone in androgen-sensitive mouse mammary carcinoma (Shionogi) cells in culture.
Topics: Androgens; Animals; Cell Division; Chlormadinone Acetate; Dihydrotestosterone; Flutamide; Male; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Mice; Progestins; Spironolactone; Tumor Cells, Cultured | 1988 |
[Indications and limits of anti-androgen therapy].
Topics: Acne Vulgaris; Alopecia; Androgen Antagonists; Chlormadinone Acetate; Cyproterone; Cyproterone Acetate; Dermatitis, Seborrheic; Drug Therapy, Combination; Female; Hirsutism; Humans; Male; Skin Diseases; Spironolactone | 1984 |